{
    "organizations": [],
    "uuid": "aea4c08716c1cc5f2dd17eb7bfebd5f7fd6a616b",
    "author": "",
    "url": "https://www.reuters.com/article/brief-galmed-pharmaceuticals-q4-loss-per/brief-galmed-pharmaceuticals-q4-loss-per-share-0-27-idUSASC09RYM",
    "ord_in_thread": 0,
    "title": "BRIEF-Galmed Pharmaceuticals Q4 Loss Per Share $0.27",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 31 AM / Updated 7 minutes ago BRIEF-Galmed Pharmaceuticals Q4 Loss Per Share $0.27 Reuters Staff March 13 (Reuters) - Galmed Pharmaceuticals Ltd: * GALMED PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE * Q4 REVENUE $300,000 VERSUS I/B/E/S VIEW $289,000 * Q4 LOSS PER SHARE $0.27 Source text for Eikon: Further company coverage:",
    "published": "2018-03-13T13:29:00.000+02:00",
    "crawled": "2018-03-13T13:52:24.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "q4",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "march",
        "reuters",
        "galmed",
        "pharmaceutical",
        "ltd",
        "galmed",
        "pharmaceutical",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "provides",
        "business",
        "update",
        "q4",
        "revenue",
        "versus",
        "view",
        "q4",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}